The annual retreat for InfiCure Bio took place last week and we had fruitful and interesting discussions on future progress of the company. Validation of the NIF mouse as a spontaneous liver model is complete and we have also added RNA sequencing data to the validation. The validation of the model as a kidney model [...]
Julia Nilsson will defend her thesis "Cellular and molecular mechanisms in immune mediated hepatic fibrosis. A study of the inflammatory and fibrosis development of the NIF mouse liver" on Friday May 15th at 9.15 CET. The defense will take place at Segerfalkssalen, BMC A10, Sölvegatan 17 in Lund, but you can also follow the event [...]
InfiCure Bio is happy to announce that Kajsa Linde has joined our team as a Senior Scientist. Prior to her position at InfiCure Bio she was working at Betagenon as a Research Engineer. We are very happy to have her on board!
Sofia and Dan from InfiCure Bio have had a very interesting trip to the Seoul area of South Korea. The purpose of the trip was to meet with potential clients and the meetings were scheduled with excellent help from Business Sweden. We are very happy with the meetings and we hope that the NIF mouse [...]
Yesterday, InfiCure Bio was announced as the winners in the category "New entrepreneur of the year" at Umeågalan. We are very proud and happy that our work to help cure fibrosis is awarded. This award shows that if you have a great team and a good ide - sky is the limit!
InfiCure Bio is nominated for Umeågalan again! This time we are one of three companies nominated in the category "New Entrepreneur of the Year", which feels very honorable. We are looking forward to a fun party and we keep our fingers crossed for winning this year. Read about the nominated companies here (in Swedish).
InfiCure Bio has been accepted to Business Swedens Catalyst program, which is a program aimed at helping companies scale globally. The focus for InfiCure Bio is the Korean market and Business Sweden will help InfiCure to evaluate the potential of the Korean market and the interest in the NIF mouse. We are very excited about this [...]
The CEO of InfiCure Bio presented the company at LSX Nordics in Stockholm on August 28th. To watch the presentation click here.
InfiCure Bio will be presenting at the LSX Nordic Congress in Stockholm on August 28th. The company will be presenting during the start up showcase as one of the growth stage private companies.
InfiCure Bio has received additional funding from NLC InfiCure Bio and Partnerinvest Övre Norrland to speed up the validation of additional indications in the NIF mouse. This is a golden opportunity to broaden our customer base and increase the revenue of the company.